Solera adds Noom weight, diabetes prevention and GLP-1 companion programs to its network

Solera Health said on Sept. 1, 2026 that it added Noom to its weight management network, giving members of participating health plans and employers access to Noom Weight, a CDC Full Plus-recognized diabetes prevention program and a GLP-1 Companion program at no extra cost ^[1][2].

Three Noom programs join the network

Solera runs a curated network of digital health programs and uses a matching process to steer members toward one that fits their needs, so plans and employers do not have to manage a separate vendor relationship for each service ^[1][2]. Noom is the newest partner in its weight management lineup ^[1].

Noom Weight is an app-based behavior-change program built on cognitive behavioral therapy rather than calorie targets or meal plans, according to the companies ^[1]. The diabetes prevention program carries CDC Full Plus recognition, which the announcement describes as the highest level of CDC approval available for diabetes prevention programs ^[1][2]. The GLP-1 Companion offers behavioral and lifestyle support to people using GLP-1 or other anti-obesity medications, and it is described as a companion to prescribed treatment rather than a replacement for it ^[2].

Solera says its network covers more than 30 clinically validated digital health programs across eight chronic condition categories. Its existing weight management lineup includes Betr, Transform, Weight Watchers and Modify Health ^[2]. Network partners are paid through a pay-for-performance, claims-based model ^[1].

The results Noom cites

The partnership announcement lists these outcomes, which Noom describes as coming from its internal data and studies ^[1][2]:

• 82% of Noom Weight members lose 5% or more of their body weight at one year ^[1][2]
• 64% of participants in the diabetes prevention program prevent or delay the onset of type 2 diabetes ^[1][2]
• Average member health care savings of $1,219 to $5,341 over two years across the two programs ^[1][2]
• An average A1C reduction of 0.28% among diabetes prevention program completers ^[1][2]

Noom says its evidence base is supported by more than 50 peer-reviewed publications ^[1]. The figures above are company-reported, and the announcement does not include independent verification of them ^[1][2].

"Every addition to our network must clear a high bar, and Noom has done so with its strength of evidence," said Kris Heinzen, chief product officer at Solera Health ^[1]. Cody Fair, Noom's chief commercial officer, said members get support "whether they're managing their weight, preventing diabetes, or navigating a GLP-1 prescription" ^[1].

Why it matters for patients

For people whose health plan or employer is a Solera customer, the change means another digital option for weight and diabetes prevention support may be reachable through their benefits instead of a separate subscription ^[1][2]. The GLP-1 Companion is meant to sit alongside medication, not replace it ^[2] — a distinction that matters as employers and health plans manage demand for obesity treatments ^[2].

The announcement does not name the health plans or employers that will offer the programs. It does not list who qualifies for the GLP-1 Companion, which GLP-1 medications it covers, or what the programs cost the plans and employers buying them. It also is not known how the new offerings interact with the weight management partners already in the network ^[1][2].

What happens next

The programs became available through Solera's network on Sept. 1, 2026 ^[1][2]. No additional milestones or timelines were announced.